Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6065 posts found.

1200px-vaccine_image_1

GSK’s RSV vaccine approved in EU for older adults

June 7, 2023 Medical Communications EU, GSK, Infections and infestations, RSV, Vaccine

GSK has announced that the European Commission (EC) has authorised Arexvy, the company’s respiratory syncytial virus (RSV) vaccine for active …
News

Bellerophon shares top-line data from phase 3 trial of INOpulse for fILD

June 6, 2023 Medical Communications Bellerophon Therapeutics, Cardiology, clinical trials, fibrotic interstitial lung disease

Bellerophon Therapeutics has announced top-line results from its phase 3 REBUILD trial evaluating the safety and efficacy of INOpulse for …
News

Quanticate announces strategic partnership with KPS Life

June 5, 2023 Medical Communications KPS Life, Pharmacy, Quanticate, fsp

Global biometric clinical research group Quanticate has announced a strategic partnership with US-based provider of functional service provision (FSP) solutions …
News

NICE approves first treatment for obstructive HCM for NHS use

June 2, 2023 Medical Communications Bristol-Myers Squibb, Cardiology, NHS, NICE, obstructive HCM

The National Institute for Health and Care Excellence (NICE) has announced that it has approved mavacamten (Camzyos) for the treatment …
News

NICE recommends Pfizer’s rimegepant for preventing episodic migraine attacks

June 2, 2023 Medical Communications NHS, NICE, Neurology, Pfizer, migraine

The National Institute for Health and Care Excellence (NICE) has announced that it has recommended an oral treatment for the …
News
towfiqu-barbhuiya-hn2hqoalbck-unsplash_1

European Parliament shares goal to tackle antimicrobial resistance

June 2, 2023 Medical Communications EU, European Parliament, Microbiology, antimicrobial resistance

The European Parliament has shared its recommendations for a “coordinated EU response to health threats posed by antimicrobial resistance,” according …
News

FDA approves ANDA of 20mg generic Nitisinone capsules

June 1, 2023 Medical Communications Analog Pharma, Dipharma, FDA, Nitisinone, Rare Diseases

Analog Pharma and Dipharma have announced that the US Food and Drug Administration (FDA) has approved their 20mg nitisinone capsules, …
News

Lonza to acquire Synaffix to strengthen ADC development

June 1, 2023 Medical Communications ADC, Lonza, Oncology, Synaffix, drug development

Global manufacturer for the pharmaceutical, biotech and nutraceutical markets, Lonza has announced that it has acquired Synaffix, a biotech company …
News

Bristol Myers Squibb’s NDA accepted by FDA

May 31, 2023 Medical Communications FDA, NDA, NSCLC, Oncology, bristol myers squibb

Global pharmaceutical company Bristol Myers Squibb (BMS) has announced that its New Drug Application (NDA) has been accepted by the …
News

Pulse Medical receives FDA BDD for its μFR system

May 30, 2023 Medical Communications BDD, Cardiology, FDA, Pulse Medical

Shanghai, China-based Pulse Medical Technology has announced that its 4th generation μFR system has received Breakthrough Device Designation (BDD) from …
News
robina-weermeijer-ihfopazzjhm-unsplash_5

AstraZeneca’s Ultomiris approved in Japan for prevention of relapses in patients with NMOSD

May 30, 2023 Medical Communications AstraZeneca, NMOSD, Neurology, Ultomiris

AstraZeneca has announced that Ultomiris (ravulizumab) has been approved in Japan as a long-acting C5 complement inhibitor for the prevention …
News

FDA approves first oral antiviral to treat adult patients with COVID-19

May 26, 2023 Medical Communications COVID-19, FDA, Infections and infestations, paxlovid

The US Food and Drug Administration (FDA) has announced that it has approved the oral antiviral Paxlovid (nirmatrelvir tablets and …
News

ZOLL remedē System receives FDA approval for sleep apnoea treatment

May 25, 2023 Medical Communications Ear Nose & throat, FDA, ZOLL, sleep apnoea

ZOLL Medical Corporation has announced that it has received approval from the US Food and Drug Administration (FDA) for its …
News
national-cancer-institute-kmvohcb-w5g-unsplash_1

AstraZeneca shares oncology data at ASCO 2023

May 25, 2023 Medical Communications ASCO, AstraZeneca, Cancer, Oncology, oncology

AstraZeneca plans to share data from its oncology pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting on …
News

Artivion receives FDA PMA approval of PerClot; transfers designation to Baxter

May 24, 2023 Medical Communications Artivion, Baxter International, Cardiology, FDA, PMA, PerClot

US cardiac and vascular surgery company Artivion has announced that the US Food and Drug Administration (FDA) has granted a …
News
News alerts and subscriptions

Latest content

AstraZeneca and MSD’s Lynparza receives NICE positive recommendation as a cancer maintenance treatment

June 9, 2023

Astellas Pharma and BMT CTN announce phase 3 data for gilteritinib

June 9, 2023

Innate Pharma announces drug researched with Sanofi receives FDA Fast Track Designation

June 8, 2023

Inventiva and Echosens collaborate to bring awareness to NASH and encourage screening for at-risk patients

June 8, 2023

Inizio launches strategic engagement offering to transform customer experiences

June 7, 2023